feed,title,long_url,short_url
Benzinga,Oyster Point Inks License Pact With Ji Xing Pharma For Dry Eye Disease Candidates In Greater China,https://benzinga.com/general/biotech/21/08/22371730/oyster-point-inks-license-pact-with-ji-xing-pharma-for-dry-eye-disease-candidates-in-greater-chin,https://j.mp/3rWh4JZ
Benzinga,"Paya Holdings Clocks 25% Revenue Growth In Q2, Lifts FY21 Gross Margin Outlook",https://benzinga.com/news/earnings/21/08/22370953/paya-holdings-clocks-25-revenue-growth-in-q2-lifts-fy21-gross-margin-outlook,https://j.mp/3fC6qmL
Benzinga,Big Tech's Q2 Results Are Poking The Regulatory Bear,https://benzinga.com/news/earnings/21/08/22373913/big-techs-q2-results-are-poking-the-regulatory-bear,https://j.mp/3ytOqCv
Benzinga,"Ocular Therapeutix, Regeneron Cull Aflibercept Agreement For Retinal Diseases",https://benzinga.com/general/biotech/21/08/22371493/ocular-therapeutix-regeneron-cull-aflibercept-agreement-for-retinal-diseases,https://j.mp/3Cm5gW4
